COVID-19 cases are expected to rise this festive season, but it’s possible to protect ourselves and our loved ones from serious illness. Here are two key updates to help you stay safe:
Exciting News: New COVID-19 Vaccine Targets Latest Variant!
The new COVID 19 vaccine COMIRNATY JN.1 is specifically designed to combat the latest variant, JN1, and is now available for individuals aged 6 months and older, including adults, infants, and children. The Therapeutic Goods Administration (TGA) approved the new COVID-19 vaccine, in October 2024.
Key Points:
- Primary Vaccination: For everyone aged 6 months and older.
- Booster Vaccination: For individuals aged 12 and above.
- Convenient Forms: Multi-dose vial (6 doses) or pre-filled syringe (1 dose), no dilution needed.
Stay up to date with your booster vaccination as recommended in the Australian Immunisation Handbook to prevent severe cases and hospitalisations.
Easier Access to COVID-19 Antivirals
Great news! The Pharmaceutical Benefits Scheme (PBS) has relaxed the eligibility criteria for subsidised COVID-19 antiviral treatments. Now, with just a positive RAT test, you can access Paxlovid or Lagevrio. Previously, a positive PCR test was needed, but that requirement has been lifted and those at high risk of severe illness from COVID-19 can now start antiviral treatment without the unnecessary hurdle of having a PCR test if they already have a positive RAT.
This change helps protect those at high risk of severe illness, especially during holiday gatherings. For more details, visit the Australian Government Department of Health and Aged Care website: Eligibility for oral COVID-19 treatments
Stay safe and healthy this festive season!
